PPARG and pulmonary fibrosis: Given the lack of effective therapy to inhibit the progression of lung fibrosis and the proposed contribution of EMT to this process, these findings support further exploration of the antifibrotic properties and mechanisms of action of PPARγ ligands in human alveolar epithelial cells to clarify their potential therapeutic benefit.